Ten Bio News
TenSkin™ – The perfect platform for microneedle applications.
Dr Paul Campbell gives his perspective on potential research avenues with TenSkin™. ‘Having worked directly with the company whilst on secondment over the past year,
Ten Bio is in Japan!
Ten Bio 社は日本にあります. In May this year, Ten Bio will attend the global session of the International Societies for Investigative Dermatology (ISID) to be held
TenSkin™ – the number one choice for skin research
Professor Giuseppe Valacchi has a global reputation for his work in expanding the understanding of cellular and molecular mechanisms that define the physio-pathological responses of skin tissue. In this interview, Professor Valacchi describes why TenSkinTM is his first choice for skin research and why he is pleased to lead Ten Bio’s Scientific Advisory Board . .
Comparative wound healing in cultured tissues vs ex-vivo tissues
This study compared a 3D cultured skin model with Ten Bio’s tensioned ex vivo TenSkin model for battlefield wound simulation. Results showed TenSkin more closely replicates healing seen in trauma patients, making it a superior platform for injury research.
Spring Conference Season
As the Northern Hemisphere welcomes Spring 2023 the new season of industry conferences and symposia kicks off. And after the return to face to face
Your Skin Research Partner – Ten Bio
service /ˈsəːvɪs/ Noun: ‘the action of helping or doing work for someone’ A note from the Chair Ten Bio’s early experience with our anchor clients has
Ten Bio named finalist in Scotland’s Life Science award.
Ten Bio is proud to announce that our company has been named one of three finalists in Scotland’s Life Science award in the category ‘Innovation
The origins of TenSkin™
Entering our third year since spin out, it’s time to celebrate the origins of our technology which has brought Ten Bio early success in a
‘When I was two, I was nearly new’ ….
‘When I was two I was nearly new’ … with thanks to A. A. Milne for the line from his 1927 poem ‘Now we are
The Sun Factor
Our patented TenSkin™ model can be used to evaluate the efficacy and tolerability of sunscreens, while also exploring the underlying biological processes that arise following exposure to the sun. In this article, the scientific team at Ten Bio explore the effects of sun exposure and the role of explant skin in the evaluation of sunscreen products and the investigation of the effects of over-exposure.
Ten Bio conferencing in 2024
Ken Fyvie shares plans for the 2024 conference season, read more to find out which events we will be attending.
Tissue integration of hyaluronic acid -containing dermal fillers: an optimized approach using tensioned ex-vivo human skin
Using the TenSkin™ ex-vivo model, this study highlights the importance of mechanical tension in assessing dermal filler integration. TenSkin™ provides a reliable platform for evaluating filler performance and guiding product development.
Precision solutions for your skin research challenges
At Ten Bio we enhance pre-clinical skin testing for our clients through the provision of our unique portfolio of explant skin platform TenSkin™. Our range includes large area models for novel drug delivery system evaluations, the adipose model for applications in subcutaneous injection delivery, and a wounded model for use in treatment & healing evaluations.
As we stride into 2024…
A very Happy and Prosperous New Year to all of Ten Bio’s clients current and future, suppliers, investors, and staff. We are all excited at the prospects of our business in 2024.
Happy Holidays 2023!
The Ten Bio team wishes you Happy Holidays and a Prosperous New Year! As our successful year comes to a close, we would like to thank our clients and business partners for their continued confidence, trust and engagement. We look forward to strengthening our collaborations in 2024 and are excited by the prospect of new partnerships and by the new science that will emerge in the coming year.